← Eichor
Study identifier: NCT06677554 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Contribution of Contrast Enhanced Ultrasound for Diagnosis of Adnexal Torsion

Condition: Adnexal Torsion  ·  Sponsor: Central Hospital, Nancy, France

PhasePhase 3
Planned participants256
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

Adnexal torsion is the rotation of the ovary around its vascular axis resulting, in the absence of treatment, ischemia that can lead to peritonitis by necrosis or impaired fertility. It is a gynecological emergency affecting 3% of women of childbearing age, including from adolescence, and requires surgical treatment as soon as possible, classically within 6 hours. The symptomatology of adnexal torsion is dominated by pelvic pain of sudden onset and variable intensity, an aspecific sign that does not allow a diagnosis of certainty. There are no biological markers and, in the context of the emergency, the only imaging examination available is pelvic ultrasound associated with a Doppler flow analysis but with a low and variable diagnostic performance depending on the studies (sensitivity variable from 46 to 73%). There are currently no tests that can provide a diagnosis of certainty. Only surgical exploration, carried out at the discretion of the practitioner on the basis of a bundle of arguments, can confirm or refute the diagnosis. However, this management strategy leads to the realization of emergency surgical interventions wrongly since 3 out of 10 women will finally not have an adnexal torsion (PMSI data from participating centers: 30 to 45% false positives). Contrast ultrasound is a technique that uses a strict intravascular product to assess the vascularization of the ovary and offers a high diagnostic performance in the context of adnexal torsion. Indeed, a retrospect…

This description comes directly from the study's public registry record.

Talk to the study team

Charline BERTHOLDT, Pr  ·  +33 383 344 312  ·  c.bertholdt@chru-nancy.fr

Dorine MANHERTZ, MSc  ·  d.manhertz@chru-nancy.fr

Always discuss trial participation with your own doctor first.

Locations (6)

CHUBesançon, FranceNot Yet Recruiting
CHUDijon, FranceNot Yet Recruiting
CHRU Nancy - Maternité RégionaleNancy, FranceRecruiting
CHUReims, FranceNot Yet Recruiting
CMCOSchiltigheim, FranceNot Yet Recruiting
CHU HautepierreStrasbourg, FranceNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06677554